Autophagy in peritoneal fibrosis.

Area of Science:

• Nephrology
• Cell Biology
• Pathology

Background:

• Peritoneal dialysis (PD) is a vital renal replacement therapy for end-stage renal disease (ESRD).
• Long-term PD can lead to peritoneal membrane (PM) damage and fibrosis (PF), causing ultrafiltration failure.
• Autophagy, a cellular degradation process, is implicated in various fibrotic conditions.

Purpose of the Study:

• To review the critical roles of autophagy in the progression of peritoneal fibrosis (PF).
• To elucidate the underlying mechanisms by which autophagy influences PF.
• To provide insights for novel therapeutic strategies targeting autophagy in PF.

Main Methods:

• Literature review of studies investigating autophagy in peritoneal fibrosis.
• Analysis of mechanisms linking autophagy activation to PF in human peritoneal mesothelial cells (HPMCs).
• Discussion of risk factors, such as high-glucose peritoneal dialysis solution (HGPDS), that modulate autophagy in PF.

Main Results:

• Autophagy activation, stimulated by factors like HGPDS, contributes to PF progression in HPMCs.
• Evidence suggests autophagy is involved in fibrosis in multiple organs, including the peritoneum.
• The precise roles and molecular mechanisms of autophagy in PF require further investigation.

Conclusions:

• Autophagy is a significant factor in the development and progression of peritoneal fibrosis.
• Targeting autophagy pathways presents a potential therapeutic avenue for managing PF in PD patients.
• Further research is needed to fully understand and exploit autophagy modulation for PF treatment.